Providing evidence-based information in a practical, easy-to-read format for practicing clinicians, investigators, industry scientists, and other entities involved in the field of neuroscience
Current Issue • July–September 2024
A Cannabinoid Hypothesis of Schizophrenia: Pathways to Psychosis
by Rachel Little, MA, and Dale D’Mello, MD Ms. Little is a science writer in Lansing, Michigan. Dr. D’Mello is Associate Professor Emeritus with the Department of Psychiatry at Michigan State University in East Lansing, [...]
Self-administration of Psilocybin in the Setting of Treatment-resistant Depression
by Ashley Lyons, MPA, PA-C Dr. Lyons is a Doctor of Medical Science in Psychiatry at Rocky Mountain University School of Health Professions in Norfolk, Virginia. Funding: No funding was provided for this article. Disclosures: [...]
Noah Syndrome: A Review Regarding Animal Hoarding with Squalor
by Leonor Moreira Abreu, MD, MSc, and João Gama Marques, MD, MSc, PhD Dr. Moreira Abreu and Prof. Gama Marques are with Clínica Universitária de Psiquiatria e Psicologia Médica, Faculdade de Medicina, Universidade de Lisboa [...]
Psychiatric Uses of Gabapentin
by Jon C. Martin, DO, and Danielle Gainer, MD Dr. Martin is with Wright Patterson Medical Center in Wright-Patterson Air Force Base, Ohio. Dr. Gainer is with Wright State University in Dayton, Ohio. Funding: No [...]
EcoMeditation Modifies Brain Resting State Network Activity
by Peta Stapleton, PhD; Dawson Church, PhD; Oliver Baumann, PhD; and Debbie Sabot, BA, Grad Dip Psych Drs. Stapleton and Baumann and Ms. Sabot are with the School of Psychology, Bond University in Gold Coast, Queensland, [...]
Abnormality of Contingent Negative Variation Correlates with Parkinson’s Disease Severity
by Plamen Tzvetanov, MD, Phd, DSc, FRCP; Ivan Lisichkov, MD, PhD; Rossen T. Rousseff MD, PhD; Vishwajit Hegde, MD, FRCP; and Sergey Kostadinov, MD, PhD Prof. Tzvetanov is with the Department of Clinical Neurophysiology, Broomfield Hospital Mid [...]
Risk Management: On the Record: Documentation of Psychiatric Treatment
by Ann L. McNary, JD Ms. McNary is Senior Risk Manager at Professional Risk Management Services (PRMS). Funding: No funding was provided for the preparation of this article. Disclosures: The author is an employee of PRMS. PRMS [...]
Letter to the Editor: Innovative Rehabilitation Technologies in the COVID-19 Era: Two Sides of the Same Coin
Funding/financial disclosures. The authors have no conflict of interest relevant to the content of this letter. No funding was received for the preparation of this letter. Innov Clin Neurosci. 2022;19(4–6):8–9. Dear Editor: In the neuroscience [...]
Past Articles
Music in Parkinson’s Disease Rehabilitation: Are We Heading in the Right Direction?
by Nicola Fiorente, MD, and Rocco Salvatore Calabrò, MD, PhD Dr. Fiorente is with Polimedica Fisio & Sport in Cittadella (PD), Italy. Dr. Calabrò is with IRCCS Centro Neurolesi “Bonino-Pulejo” in Messina, Italy. Funding: No [...]
Clinical Outcome Assessment Instruments in Schizophrenia: A Scoping Literature Review with a Focus on the Potential of Patient-reported Outcomes
by Leslie Citrome, MD, MPH; Marko A. Mychaskiw, BSRPh, MS, PhD; Alma Cortez, BA; Mark Opler, MPH, PhD; Liza Sopina, MPH, PhD; and Sameer Kotak, MS, MBA Dr. Citrome is with Department of Psychiatry and [...]
Medical Student-patients: Mental Wellness During the Pandemic
by Kari Harper, MD; Nita Bhatt, MD, MPH; and Julie P. Gentile, MD, MBA Dr. Harper is Assistant Professor, Department of Psychiatry at Wright State University in Dayton, Ohio. Dr. Bhatt is Associate Professor and [...]
The Impact of Psilocybin on Patients Experiencing Psychiatric Symptoms: A Systematic Review of Randomized Clinical Trials
by Waguih William IsHak, MD, FAPA; Paloma Garcia, BS Candidate; Rachel Pearl, MD; Jonathan Dang, MD; Catherine William, BS; Jayant Totlani, BS, DO candidate; and Itai Danovitch, MD, MBA Drs. IsHak, Pearl, Dang, and Danovitch [...]
Seizure and Other Catastrophes due to Bupropion Overdose: Recent Case Report and Review of Published Cases
by Isha Snehal, MD; Garret Lorenzen, MS; and Ashish Sharma, MD Dr. Snehal is with Department of Neurological Sciences, University of Nebraska Medical Center in Omaha, Nebraska. Mr. Lorenzen is with College of Medicine, University [...]
Risk Management: Treating Patients at Risk for Suicide: Part 1
by Donna Vanderpool, MBA, JD Ms. Vanderpool is Director of Risk Management at Professional Risk Management Services (PRMS). Funding: No funding was provided for the preparation of this article. Disclosures: The author is an employee [...]
Letter to the Editor: Open Bite Malocclusion Following Aripiprazole Treatment in Children and Adolescents
Funding/financial disclosures. The author has no conflicts of interest relevant to the content of this letter. No funding was received for the preparation of this letter. Innov Clin Neurosci. 2023;20(4–6):9–10. Dear Editor: Aripiprazole is one [...]
Letter to the Editor: What About the Hippotherapy Benefit-cost Ratio in Everyday Clinical Practice? The Physician Point of View
Funding/financial disclosures. The authors have no conflicts of interest relevant to the content of this letter. No funding was received for the preparation of this letter. Innov Clin Neurosci. 2023;20(4–6):8. Dear Editor: Hippotherapy is [...]